Amgen (AMGN) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $3.2 billion.
- Amgen's Consolidated Net Income rose 1363.96% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year increase of 6560.28%. This contributed to the annual value of $4.1 billion for FY2024, which is 3910.97% down from last year.
- Amgen's Consolidated Net Income amounted to $3.2 billion in Q3 2025, which was up 1363.96% from $1.4 billion recorded in Q2 2025.
- In the past 5 years, Amgen's Consolidated Net Income registered a high of $3.2 billion during Q3 2025, and its lowest value of -$113.0 million during Q1 2024.
- Moreover, its 5-year median value for Consolidated Net Income was $1.6 billion (2022), whereas its average is $1.6 billion.
- Per our database at Business Quant, Amgen's Consolidated Net Income tumbled by 10397.75% in 2024 and then soared by 163097.35% in 2025.
- Quarter analysis of 5 years shows Amgen's Consolidated Net Income stood at $1.9 billion in 2021, then decreased by 14.9% to $1.6 billion in 2022, then plummeted by 52.54% to $767.0 million in 2023, then fell by 18.25% to $627.0 million in 2024, then surged by 412.92% to $3.2 billion in 2025.
- Its last three reported values are $3.2 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.7 billion during Q1 2025.